WallStreetZenWallStreetZen

NASDAQ: PRE
Prenetics Global Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRE

Based on 1 analyst offering 12 month price targets for Prenetics Global Ltd

Min Forecast
$9.00+28.39%
Avg Forecast
$9.00+28.39%
Max Forecast
$9.00+28.39%

Should I buy or sell PRE stock?

Based on 1 analyst offering ratings for Prenetics Global Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRE stock forecasts and price targets.

PRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-16

1 of 1

Forecast return on equity

Is PRE forecast to generate an efficient return?

Company
-8.16%
Industry
0.06%
Market
56.76%
PRE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRE forecast to generate an efficient return on assets?

Company
-6.44%
Industry
10.6%
PRE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRE earnings per share forecast

What is PRE's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.12
Avg 2 year Forecast
-$1.01

PRE vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
PRE$7.01$9.00+28.39%Strong Buy
FONR$14.55N/AN/A
NOTV$2.22$5.00+125.23%Strong Buy
OCX$2.65$5.42+104.42%Buy
VNRX$0.64$3.50+446.88%Strong Buy
View Top Diagnostic & Research Stocks

Prenetics Global Stock Forecast FAQ

Is Prenetics Global Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PRE) stock is to Strong Buy PRE stock.

Out of 1 analyst, 1 (100%) are recommending PRE as a Strong Buy, 0 (0%) are recommending PRE as a Buy, 0 (0%) are recommending PRE as a Hold, 0 (0%) are recommending PRE as a Sell, and 0 (0%) are recommending PRE as a Strong Sell.

If you're new to stock investing, here's how to buy Prenetics Global stock.

What is PRE's earnings growth forecast for 2025-2026?

(NASDAQ: PRE) Prenetics Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 41.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Prenetics Global's earnings in 2025 is -$48,127,190.On average, 1 Wall Street analyst forecast PRE's earnings for 2025 to be -$27,566,307, with the lowest PRE earnings forecast at -$27,566,307, and the highest PRE earnings forecast at -$27,566,307.

In 2026, PRE is forecast to generate -$13,133,005 in earnings, with the lowest earnings forecast at -$13,133,005 and the highest earnings forecast at -$13,133,005.

What is PRE's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: PRE) forecast ROE is -8.16%, which is considered weak.

What is PRE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PRE price target, the average PRE price target is $9.00, with the highest PRE stock price forecast at $9.00 and the lowest PRE stock price forecast at $9.00.

The Wall Street analyst predicted that Prenetics Global's share price could reach $9.00 by Jan 16, 2026. The average Prenetics Global stock price prediction forecasts a potential upside of 28.39% from the current PRE share price of $7.01.

What is PRE's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: PRE) Prenetics Global's current Earnings Per Share (EPS) is -$3.83. On average, analysts forecast that PRE's EPS will be -$2.12 for 2025, with the lowest EPS forecast at -$2.12, and the highest EPS forecast at -$2.12. In 2026, PRE's EPS is forecast to hit -$1.01 (min: -$1.01, max: -$1.01).

What is PRE's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: PRE) forecast ROA is -6.44%, which is lower than the forecast US Diagnostics & Research industry average of 10.6%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.